505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA
Similar to 505(b)(2)
ACR - American College of RadiologyACRA - Associate Commissioner for Regulatory Affairs
ACS - Automated Commercial System
ACS (CBER) - Analytical Chemistry Staff CBER
ACS (CDER) - Advisors and Consultants Staff CDER
ACSM - American College of Sports Medicine
ACT - AIDS Clinical Trials
View all in FDA